BioWorld
-
Bully gene thesis at door as Crysvita dances in the round for Ultragenyx
-
South Korea’s VCs invested a record high $930M in bio and medical ventures last year
-
Today's news in brief
-
Belviq bows out of U.S. market amid cancer concerns
-
Zhittya gains approval for phase I Parkinson’s trial in Mexico
-
Bench Press for Feb. 14, 2020
-
Holiday notice
-
Shares of Revolution in surgent mode as Wall Street ra-RAS $238M IPO
BioWorld MedTech
-
Researchers develop diagnostic system that detects up to 40 infectious respiratory pathogens in one test
-
Advamed questions EPA methodology for risk associated with ethylene oxide
-
Today's news in brief
-
Surgeons carry out first robotic supermicrosurgery
-
Surgeons come together to create Field Orthopaedics to address market shortcomings
-
Med-tech gainers and losers for Feb. 10-14, 2020
-
BioWorld MedTech’s Neurology Extra for Feb. 14, 2020
-
Medtronic acquisition aims to increase precision, predictability in robotic surgery
-
Cloudcath raises $12M to back at-home peritoneal dialysis monitoring
BioWorld Asia
-
Coronavirus outbreak in China sparks fears of disruption for global drug supplies
-
Hong Kong researchers create fastest coronavirus diagnostic test to date
-
Today's news in brief
-
Coronavirus outbreak pushes Chinese biotech stocks higher despite market downturn
-
Not yet a pandemic, 2019-nCoV has echoes of MERS, SARS, flu
-
Reactants ignite, China syndrome melts down FDA drug-quality meeting
-
Researchers cast wide net for rapid-draw weapons in 2019-nCoV fight
